GENEVA, Dec. 22 -- MERCK PATENT GMBH (Frankfurter Strasse 25064293 Darmstadt) filed a patent application (PCT/EP2025/066182) for "MUC-1 CONDITIONAL CD40 AGONISTS" on Jun 10, 2025. With publication no. WO/2025/257220, the details related to the patent application was published on Dec 18, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): SHA, Weixiao (c/o Merck Healthcare KGaAFrankfurter Strasse 25064293 Darmstadt), GUENTHER, Ralf (c/o Merck Healthcare KGaAFrankfurter Strasse 25064293 Darmstadt), ZIELONKA, Stefan (c/o Merck Healthcare KGaAFrankfurter Strasse 25064293 Darmstadt), KRAH, Simon (c/o...